Epstein Secrets

ww.washingtontimes.corn/news/2020/jul/23/lockdowns-testing-dont-cut-covid- deaths-lancet/> (7/23, Scarborough, 492K) reports a study published in the Lancet concludes that "lockdowns and wide testing do not reduce [COVID-19] death rates." The study's authors write, "Government actions such as border clo

oxychloroquine," but in the US the drug "does not have nearly the official imprimatur that it does in parts of Latin America." In Brazil, "President Jair Bolsonaro has relentlessly promoted the drug." Meanwhile, "governments in El Salvador, Peru and Paraguay have bought hydroxychloroquine to treat coronavirus."

acts. Study Concludes Lockdowns, Testing Do Not Reduce Death Rates. The Washington Times (7/23, Scarborough, 492K) reports a study published in the Lancet concludes that "lockdowns and wide testing do not reduce [COVID-19] death rates." The study's authors write, "Government actions such as border clo

xychloroquine," but in the US the drug "does not have nearly the official imprimatur that it does in parts of Latin America." In Brazil, "President Jair Bolsonaro has relentlessly promoted the drug." Meanwhile, "governments in El Salvador, Peru and Paraguay have bought hydroxychloroquine to treat coronavirus.

k on the race to develop a COVID vaccine. Early results we've been waiting for from researchers at Oxford will be published next week in the journal Lancet. What we'll be looking for is to see if this vaccine could offer double defense against the virus, meaning it doesn't just boost antibodies for COV

the spread south of the border." Bolsonaro Tests Positive For Coronavirus For A Second Time. Reuters (7/15, Benassatto) reports Brazilian President Jair Bolsonaro told reporters Wednesday that he has tested positive for coronavirus for a second time, "a week after he announced he had become ill with COVID-19,

acts. Study Concludes Lockdowns, Testing Do Not Reduce Death Rates. The Washington Times (7/23, Scarborough, 492K) reports a study published in the Lancet concludes that "lockdowns and wide testing do not reduce [COVID-19] death rates." The study's authors write, "Government actions such as border clo

xychloroquine," but in the US the drug "does not have nearly the official imprimatur that it does in parts of Latin America." In Brazil, "President Jair Bolsonaro has relentlessly promoted the drug." Meanwhile, "governments in El Salvador, Peru and Paraguay have bought hydroxychloroquine to treat coronavirus.